Your browser doesn't support javascript.
loading
Prediction of Long-Term Incidence of Chronic Cardiovascular and Cardiopulmonary Diseases in Primary Care Patients for Population Health Monitoring: The Intermountain Chronic Disease Model (ICHRON).
May, Heidi T; Lappé, Donald L; Knowlton, Kirk U; Muhlestein, Joseph B; Anderson, Jeffrey L; Horne, Benjamin D.
Afiliación
  • May HT; Intermountain Medical Center Heart Institute, Salt Lake City, UT. Electronic address: heidi.may@imail.org.
  • Lappé DL; Intermountain Medical Center Heart Institute, Salt Lake City, UT.
  • Knowlton KU; Intermountain Medical Center Heart Institute, Salt Lake City, UT; Department of Medicine, University of Utah, Salt Lake City, UT.
  • Muhlestein JB; Intermountain Medical Center Heart Institute, Salt Lake City, UT; Department of Medicine, University of Utah, Salt Lake City, UT.
  • Anderson JL; Intermountain Medical Center Heart Institute, Salt Lake City, UT; Department of Medicine, University of Utah, Salt Lake City, UT.
  • Horne BD; Intermountain Medical Center Heart Institute, Salt Lake City, UT; Department of Medicine, University of Utah, Salt Lake City, UT.
Mayo Clin Proc ; 94(7): 1221-1230, 2019 07.
Article en En | MEDLINE | ID: mdl-30577973
ABSTRACT

OBJECTIVE:

To apply the practical parsimonious modeling method of the Intermountain Mortality Risk Score in a primary care environment to predict chronic disease (ChrD) onset. PATIENTS AND

METHODS:

Primary care patients free of ChrD (women n=98,711; men n=45,543) were evaluated to develop (70% [n=95,882] of patients) and validate (the other 30% [n=48,372]) the sex-specific Intermountain Chronic Disease Risk Score (ICHRON) if seen initially between January 1, 2003, and December 31, 2005. The sex-specific ICHRON was composed of comprehensive metabolic profile and complete blood count components and age. The primary outcome was the first diagnosis of coronary artery disease, myocardial infarction, heart failure, atrial fibrillation, stroke, diabetes, renal failure, chronic obstructive pulmonary disease, peripheral vascular disease, or dementia within 3 years of baseline.

RESULTS:

At 3 years, 9.0% of men (mean age, 44±16 years) and 6.6% of women (mean age, 42±16 years) received a diagnosis of ChrD. In the derivation population, C-statistics were 0.783 (95% CI, 0.774-0.791) for men and 0.774 (95% CI, 0.767-0.781) for women. In the validation population, C-statistics were 0.774 (95% CI, 0.762-0.786) for men and 0.762 (95% CI, 0.752-0.772) for women. Evaluation of 10-year outcomes for ICHRON and analysis of its association with each outcome individually at 3 years revealed similar predictive ability.

CONCLUSION:

An augmented intelligence clinical decision tool for primary care, ICHRON, is developed using common laboratory parameters, which provides good discrimination of ChrD risk at 3 and 10 years.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Atención Primaria de Salud / Enfermedad Crónica / Valor Predictivo de las Pruebas / Enfermedad Pulmonar Obstructiva Crónica / Salud Poblacional / Cardiopatías Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Mayo Clin Proc Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Atención Primaria de Salud / Enfermedad Crónica / Valor Predictivo de las Pruebas / Enfermedad Pulmonar Obstructiva Crónica / Salud Poblacional / Cardiopatías Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Mayo Clin Proc Año: 2019 Tipo del documento: Article